穿刺导管市场（2026—2031）
穿刺导管市场规模预计由2026年的7.2亿美元增至2031年的10亿美元，预测期复合年增长率为6.70%。北美是当前最大市场，亚太地区增长最快。
市场研究正文
规模、增长、细分、驱动因素与关键问题
当前质量分 100.00，审核状态 accepted。结构化字段已按 RoboInd 内容层级组织。
核心结论
穿刺导管市场规模预计由2026年的7.2亿美元增至2031年的10亿美元，预测期复合年增长率为6.70%。北美是当前最大市场，亚太地区增长最快。
市场走势
结构化指标
| 指标 | 年份 | 数值 | 性质 |
|---|---|---|---|
| 复合年增长率 | 2031 | 6.7% | 机构预测 |
| 市场规模 | 2026 | USD 0.72 billion | 机构预测 |
| 市场规模 | 2031 | USD 1 billion | 机构预测 |
细分市场份额
市场结构
| 维度 | 细分项 | 年份 | 份额 |
|---|---|---|---|
| application | drug administration | 2025 | 55.660% |
| end_user | hospitals and health systems | 2025 | 65.890% |
| geography | North America | 2025 | 42.350% |
| procedure | paracentesis | 2025 | 56.770% |
| product_type | large-bore catheters | 2025 | 63.450% |
关键结论
- application 维度中，drug administration 在 2025 年的公开份额为 55.66%。
- end_user 维度中，hospitals and health systems 在 2025 年的公开份额为 65.89%。
- geography 维度中，North America 在 2025 年的公开份额为 42.35%。
- procedure 维度中，paracentesis 在 2025 年的公开份额为 56.77%。
- product_type 维度中，large-bore catheters 在 2025 年的公开份额为 63.45%。
主要参与者
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Cardinal Health, Inc.
- Cook Medical LLC
- Merit Medical Systems, Inc.
增长驱动因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Rising procedure volumes for ascites and pleural effusion | +2.100% | Global | Short term (≤ 2 years) |
| Increasing adoption of image-guided centesis | +1.800% | North America and Europe | Short term (≤ 2 years) |
| Expansion of ambulatory and outpatient procedures | +0.900% | North America, Europe, and Asia-Pacific | Medium term (2-4 years) |
| Growing demand for recurrent and home-based fluid drainage | +1.000% | North America and Europe, with spillover to Asia-Pacific | Medium term (2-4 years) |
| Standardization of closed, valved drainage workflows | +0.500% | Global | Medium term (2-4 years) |
| Expansion of palliative drainage for advanced cancer | +0.800% | North America, Europe, and Asia-Pacific | Long term (≥ 4 years) |
市场制约因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Premium pricing and reimbursement variability | -0.900% | Global, particularly Asia-Pacific and South America | Short term (≤ 2 years) |
| Procedure-related complications and device recalls | -0.600% | North America and Europe | Short term (≤ 2 years) |
| Training dependence for safe placement and drainage-volume control | -0.400% | Global, particularly Asia-Pacific and the Middle East and Africa | Medium term (2-4 years) |
| Limited interoperability between catheters, tubing, and collection systems | -0.300% | Global | Long term (≥ 4 years) |
报告关注的关键问题
What is the projected value of the centesis catheters market by 2031?
The centesis catheters market is projected to reach USD 1.0 billion by 2031, from USD 0.72 billion in 2026, at a CAGR of 6.70%.
Which catheter type held the largest share in 2025?
Large-bore catheters held 63.45% of revenue in 2025 because they remain established in high-volume inpatient drainage workflows.
Which procedure is expected to grow the fastest through 2031?
Thoracentesis is forecast to grow at a 9.80% CAGR as pleural drainage shifts toward outpatient and ambulatory care.
Why are indwelling catheters gaining attention in cancer care?
They can reduce repeat hospital visits and support home-based drainage for patients with malignant ascites or pleural effusion.
Which region is expected to expand the fastest?
Asia-Pacific is projected to record a 10.88% CAGR through 2031, supported by hospital expansion and chronic disease management in China and India.
What can limit wider use of centesis catheters?
Reimbursement variability, premium kit costs, procedure complications, training requirements, and limited system compatibility can slow adoption.
市场概览
- 增长最快市场：亚太地区
- 最大市场：北美
- 市场集中度：中等
查看来源：Mordor Intelligence